Description: Renalytix AI plc focuses on the development of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease. Its solutions are used in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company was incorporated in 2018 and is based in Cardiff, the United Kingdom. Renalytix AI plc is a subsidiary of EKF Diagnostics Holdings plc.
Home Page: renalytix.com
1460 Broadway
New York,
NY
10036
United States
Phone:
646 397 3970
Officers
| Name | Title |
|---|---|
| Mr. James R. McCullough M.B.A. | CEO & Director |
| Mr. Fergus Fleming | CTO & Executive Director |
| Dr. Michael J. Donovan M.D., Ph.D. | Chief Medical Officer |
| Mr. Julian Huw Baines M.B.E. | Executive Chairman |
| Mr. Howard B. Doran Jr. | President |
| Mr. Joel R. Jung MBA | Chief Financial Officer |
| Mr. Salim Gulamabbas Hamir F.C.A. | Company Secretary |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Technology |
| GIC Sub-Industry: | Health Care Technology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 8.3465 |
| Price-to-Sales TTM: | 3.7725 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |